Carlyle has ended its pursuit to purchase a stake in Veritas-backed Cotiviti, Bloomberg’s Gillian Tan and Michelle F. Davis report, citing people with knowledge of the matter. Veritas began informing limited partners of the development on Tuesday, the authors note. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CG:
- Carlyle (NASDAQ:CG) and Veritas Fail to Reach a Deal
- Carlyle Group price target lowered to $33 from $34 at BofA
- Carlyle Group price target lowered to $46 from $48 at Piper Sandler
- ICU teams with Linden Capital for Medtronic assets bid, Reuters reports
- Carlyle, Lone Star join Apollo for Arconic bid, Dealreporter says